News

Research shows direct associations between unmanaged, severe OSA and cardiovascular event incidence. An expert reviews mechanisms and cross-sectional studies.

Though select diabetes guidelines suggest the use of continuous glucose monitoring on patients with diabetic patients on intensive therapy, the potential benefits on type 2 patients without insulin and pre-diabetes patients has yet to be fully explored.

Though limited data exist, Dr. Dunfaif believes there’s are indications of cardiovascular risk in patients of all ages with polycystic ovary syndrome.

The Tulane Chief of Endocrinology recalls Dr. Frederick Banting's historic discovery in 1921, and how it still impacts diabetes care today.

From evidence-based and plant-based diets, to promising new strategies involving SGLT2 inhibitors, Dr. Taub detailed preventative strategies used to combat cardiovascular disease.

A look at how European experts have shaped risk assessment through demographic-centric algorithms.

Dr. Grunberger believes that the improved time in range brought on by continual glucose monitoring could lead to a reduction in hypoglycemia and risk of cardiovascular events, as well as promising monetary benefits for patients and payers.

While some treatments did not result in reduced instances of strokes in patients, others such as GLP-1 agonists provided Dr. Inzucchi with new opportunities for cardiovascular disease prevention.

Updates to the ADA Standards of Medical Care emphasize the utility of SGLT2 inhibitors and GLP-1 agonists. Yet, initiation is lacking from prescribers.

Dr. Donna H. Ryan presents data on emerging pharmacological strategies that could aid patients in achieving optimal weight loss and prevent risk of cardiovascular events and diabetes.

While drivers of gestational diabetes are not fully evidenced, data shows how it's linked to great likelihood of type 2 diabetes and cardiovascular events.

Despite having lower burden of several cardiovasculard disease risk factors, cardiovascular mortality is higher in African Americans, which Dr. Dagogo-Jack attributes to disparities in patient care.

Dr. Peter Grant admits that the phenotypes surrounding certain cardiovascular diseases are complex, but notes treatments can be recommended based on individual patients’ complications.

Though the trial observing dapagliflozin for severe COVID-19 did not achieve statistical significance, investigators believe it showed the agent's benefit in acute illness.

In his presentation at TMIOA, Dr. Inzucchi referenced several diabetes medications and glucose management methods that resulted in a reduction of stroke risk in patients.

There was an association between maternal BMI prepregnancy and offspring ADHD risk.

Many predict there will be a lasting labor shortage in nursing in the future.

Derek Jones, VP Enterprise Strategy, Americas at Deputy, explains how healthcare facilities should hire extra shift workers.

The new assay was 100% on both sensitivity and specificity for detecting C difficile infections from rectal swabs.

Data show no patients in the study (n = 510) had BCVA worse than 0.3 (log MAR 0.48) due to diabetic retinopathy.

Serum concentrations of aminotransferases improved for HCC-DAA and DAA-HCC groups 1 year following surgery.

Patients with lower pain intensity were more accepting of telemedicine treatments.

A rarity in biologic treatments for patients with moderate-to-severe plaque psoriasis, Dr. Miller notes that patients treated with guselkumab recorded overwhelmingly positive PASI scores.

One lot of the vancomycin kits mistakenly contained a first omeprazole diluent.

Despite cautionary programs and air purifiers having been installed in the school to alleviate allergic symptoms, investigators found they did not significantly reduce symptom-days.

Overall positive genetic test results for variants was 10.1% for patients diagnosed with AF before 66 years of age and 16.8% in patients diagnosed before 30 years of age.

Obstructive sleep apneas and overnight hypoxemia are more likely to develop in patients with sickle cell disease.

Mean age of diabetes diagnosis was 4 - 7 years earlier among non-Hispanic Black and Mexican American adults, in comparison to non-Hispanic White adults.